1/25
Looks like no tags are added yet.
What is acute coronary syndrome?
Refers to any group of syndromes attributed to the obstruction of the coronary arteries
This includes:
Non ST elevated myocardial infarction
ST elevated myocardial infarction
Unstable angina
What is myocardial infarction?
A heart attack (MI) is usually caused by a blood clot, which stops the blood flowing to a part of the heart muscle
Common cause of a heart attack is a blood clot that forms inside a coronary artery, or one of its branches
A clot may form if there is atheroma (plaques) that develop within the inside lining of arteries
There is a rise in the cardiac enzyme troponin - increases when cells are damaged
Troponin I and T become detectable in serum 3 to 6 hours after infarction, peak at 12-24 hours, and remain raised for up to 14 days
Troponins are therefore usually testes 6 and 12 hours after the onset of pain
Myocardial infarction: 2 types
ST elevated
There is an elevation on the ST segment of a 12 lead ECG
Non ST elevated
There is no change in the 12 lead ECG

Causes of MI
Formation of an atherosclerotic plaque
Stable plaques can cause arterial blood flow obstruction and symptoms of angina
Unstable plaques are prone to rupture and can form a thrombus
Risk factors - modifiable and non-modifiable
Modifiable
Tobacco smoke
High cholesterol
High BP
Physical inactivity
Obesity
Diabetes
Non-modifiable
Increased age - 83% that die are over 65 years
Male sex
Family history
Race
Symptoms of MI
Sudden onset ‘crushing’ chest pain
Originates in the center of the chest then radiates to the arms, neck or jaw
Associated with sweating and shortness of breath
Sometimes it can be difficult to distinguish between heart related chest pain and GORD
Treatment of ST elevation MI
Aspirin 300 mg
Coronary reperfusion therapy
Either primary percutaneous coronary intervention with additional antiplatelet agent e.g. ticagrelor or prasugrel
Or fibrinolysis e.g. reteplase, tenecteplase
Coronary angiography
Medical arrangement and secondary prevention
Pain relief, anti-emetics and glycaemic control
Prasugrel
Prasugrel – Triton TIMI 38
An inhibitor of platelet activation and aggregation through the irreversible binding of its active metabolite to the P2Y12 class of ADP receptors on platelets
Prasugrel in combination with aspirin is recommended as an option for preventing atherothrombotic events in ST-elevation myocardial infarction (STEMI) having primary or delayed PCI
Ticagrelor
PCI and medical management
ADP receptor antagonist
Side effects: dyspnoea, haemorrhage
PLATO-trial
Advanatge may lie in faster onset of action
Cangrelor
Cangrelor, in combination with aspirin, is licensed for the reduction of thrombotic cardiovascular events in patients with coronary artery disease undergoing percutaneous coronary intervention (PCI) who have not received treatment with oral clopidogrel, prasugrel or ticagrelor prior to the procedure and in whom oral therapy with these drugs is not suitable
Cangrelor is to be used under expert supervision only
Secondary Prevention of STEMI
Aspirin at low dose lifelong
If patient has had a stent dual antiplatelet therapy may be required (clopidogrel)
Ticagrelor may be used in combination with low-dose aspirin is recommended for up to 12 months
PPI (lansoprazole) may be required to reduce GI side effects
Beta blockers can reduce mortality after MI
Lipid lowering treatment
ACE inhibitors
Aldosterone antagonists e.g. epleronone may be offered to patients with heart failure post MI
Low-dose rivaroxaban, in combination with aspirin alone or aspirin and clopidogrel, is licensed for the prevention of atherothrombotic events following STEMI
Unstable angina
If a patient presents with symptoms of MI but not a sufficient troponin rise or no troponin rise:
They may or may not have changes on their ECG
They are then termed as having unstable angina
Treatment of NSTEMI and Unstable Angina
Aspirin – loading dose of 300mg
Ticagrelor (180 mg loading dose)
Consider eptifibatide and tirofiban in patients who will undergo coronary angioplasty or abciximab as an adjunct to PCI
Antithrombin therapy with either fondaparinux or unfractionated heparin
Coronary angiography with or without PCI or coronary artery bypass graft (CABG)
Pain relief and anti-emetics
Secondary prevention of NSTEMI and Unstable Angina
Dual antiplatelet therapy
Lipid lowering medication - statins
ACE inhibitors
Beta blockers
Cardiac rehabilitation
This should be offered to patients soon after cardiac event
The benefits of the program should be highlighted
Should start within 10 days of discharge from hospital
What is stable angina?
Angina is chest pain or discomfort that is caused when heart muscle does not get enough blood
Angina results from the demands of the myocardium being unable to be met by blood supply
This usually implies narrowing of one of more coronary arteries and it tends to occur at times when the heart has to do more work - e.g. exercise or emotional stress
Stable and unstable angina
In stable angina: the pain is precipitated by predictable factors - usually exercise
In unstable angina: angina occurs at any time and should be considered and managed as a from of acute coronary syndrome
The aim of management is to:
Stop or minimise symptoms
To improve quality of life and long-term morbidity and mortality
Anginal pain
Is constricting discomfort in the front of chest, neck, shoulders, jaws or arms
Precipitated by physical exertion
Relieved by rest or GTN in about 5 minutes
Stable angina management - beta blockers and calcium channel blockers
GTN for rapid symptom relief
Offer either a beta-blocker or calcium-channel blocker as first- line treatment
If the symptoms are not adequately controlled (or the patient cannot tolerate one option) consider switching to the other option, or using a combination of the two
If a patient's symptoms are not adequately controlled on one drug and the other is either contra-indicated or not tolerated, consider:
A long-acting nitrate
Ivabradine (a selective inhibitor of sinus node pacemaker activity)
Ranolazine (reduces myocardial ischaemia by acting on intracellular sodium currents)
If using a calcium-channel blocker with either beta-blocker or ivabradine, use a slow-release nifedipine, amlodipine or felodipine
If the patient cannot tolerate beta-blockers or calcium-channel blockers (or they are contra- indicated), consider monotherapy with:
A long-acting nitrate
Ivabradine
Ranolazine
Stable angina management - 3rd anti-angina drugs
Only add a third anti-angina drug when:
The person's symptoms are inadequately controlled with two drugs
The person is waiting for revascularisation or it is not considered appropriate or acceptable
Only consider nicorandil when other medicines are unsuitable, because of the risk of ulceration
Nicorandil is a compound with properties of a nitrate but also activates ATP-dependent potassium channels
It opens these channels, which causes the muscle cells to relax
When the muscle cells in the walls of blood vessels relax, it allows the blood vessels to widen
When is coronary revascularisation required?
In those at high risk and those who have failure to be controlled by medical therapy
Nitrates
Protect against exercise induced ischaemia
Short acting vs long acting
Tolerance
Adjunctive therapy, not monotherapy
Side effects - headache
Mimic endogenous NO causing vasodilation
Improve coronary blood flow, reduce preload (dilate veins) and afterload (dilate arteries)
Nitrates relax the vascular smooth muscle by releasing nitric oxide
Nitrates - tolerance, side effects and drug interaction
Tolerance
A main limitation-develops rapidly
A nitrate free period of few hours each 24 hours is of benefit
Should coincide with period of lowest risk-usually night time
Side effects
Headache and cutaneous flushing
Other side effects include: postural hypotension and reflex tachycardia
Drug interaction
The phosphodiesterase-5 (PDE5) inhibitor - sildenafil (treatment of erectile dysfunction)
Sildenafil is contraindicated in combination with nitrates due to the risk of interaction that can result in severe hypotension and death
Patient care after a MI
Adherence to diet, exercise and smoking cessation should be encouraged
Encourage attending cardiac rehabilitation
Patients beliefs about medicines and medication taking behaviour (adherence) is important
Divide medications into prescribed to reduce reinfarction and mortality and prescribed for symptom control
Patients should be encouraged to identify concerns openly and honestly as possible
Patients have a good reason to be anxious but some restrict their activity out of fear of angina and infarction
Patient care after a MI - common problems to discuss
Use of nitrates
Use of NSAID and ACE inhibitors.
Speed is essential if fibrinolytic drugs are needed after an infarction
Aspirin and GIT bleeding take aspirin with food and water
Unpleasant beta-blockers side effects
How are stents placed? (diagram)
